Sanofi Genzyme - Regeneron
The Sanofi Genzyme and Regeneron collaboration is committed to translating cutting-edge science into groundbreaking medicines for patients with serious needs. Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. Since 2007, Regeneron and Sanofi have collaborated to discover, develop, manufacture and commercialize fully human monoclonal antibodies.
The DePuy Synthes Companies are part of the Johnson & Johnson Family of Companies
. We offer the world’s most comprehensive portfolio of orthopaedic and neuro products and services for joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials.
At DJO Global, our aim is to enable all people to regain the joy and comfort of natural motion. As a leading healthcare company, we provide the facilities, resources and people to deliver state-of-the-art medical devices and services that enable people to live life to the fullest while maximizing end-users' comfort. We value an open dialogue with our customers to gather insights that guide our innovation and continuous improvement.
Radius is a science-driven biopharmaceutical company committed to developing innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases. Established in 2003 by world-renowned researchers, our history is rooted in science and our R&D efforts are focused on disease areas with unmet needs.